👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Prof
Prof Matthew Winter
Oncology
English
7,494+
Patients seen
8
Years in practice
9
Publications
1
Languages spoken
About
Professor Matt Winter has been a Consultant in Medical Oncology since January 2011 after completing his specialist training in medical oncology in Sheffield, including a Doctor ofMedicine clinical and translational research degree in breast cancer. He specialises in and has extensive experience in all aspects of non-surgical systemic breast cancer treatments and has a busy NHS and clinical trial practice. He was also
the Lead Breast Cancer clinician at Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust from 2014 - 2023 and is currently the breast cancer sub-speciality lead for the NIHR Yorkshire and Humber Clinical Research Network.
In 2022, he became Director of the Sheffield Trophoblastic Disease Centre and since 2018 has also been a member of the Executive Committee of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD), currently as secretary (since 2021)
and President-Elect (from May 2025).
He has a keen interest in clinical trials and is an author on over 100 published original articles, reviews or conference abstracts in peer reviewed journals in both breast cancer
and Gestational Trophoblastic Disease. In 2024, he was appointed as Honorary Professor of Medical Oncology, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield.
Professor Winter prides himself on establishing excellent rapport with his patients through clear and compassionate communication and promoting an individualised
patient-centred approach.
the Lead Breast Cancer clinician at Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust from 2014 - 2023 and is currently the breast cancer sub-speciality lead for the NIHR Yorkshire and Humber Clinical Research Network.
In 2022, he became Director of the Sheffield Trophoblastic Disease Centre and since 2018 has also been a member of the Executive Committee of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD), currently as secretary (since 2021)
and President-Elect (from May 2025).
He has a keen interest in clinical trials and is an author on over 100 published original articles, reviews or conference abstracts in peer reviewed journals in both breast cancer
and Gestational Trophoblastic Disease. In 2024, he was appointed as Honorary Professor of Medical Oncology, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield.
Professor Winter prides himself on establishing excellent rapport with his patients through clear and compassionate communication and promoting an individualised
patient-centred approach.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Prof Matthew Winter
Education & training
-
2008–2014 MD · Medicine and Surgery
-
2014–2018 Residency · Oncology
-
2018–2019 Fellowship · Subspecialty training
Career & appointments
-
2018-09–2019-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Generali Healthcare · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 3,039 |
| Annual physical exam | 99395 | 129 |
| Vaccination administration | 90471 | 2,561 |
| Minor procedure (skin) | 17110 | 2,958 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 4
-
European registry analysis of Oncology outcomes
DOI: 10.5057/euroclin.2025.0 · PMID: 35771538 · cited by 7
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.9225/euroclin.2024.1 · PMID: 31192779 · cited by 181
-
European registry analysis of Oncology outcomes
DOI: 10.5553/euroclin.2023.2 · PMID: 35163362 · cited by 35
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2019
- national college of family doctors — Member · since 2019
- European Union of Medical Specialists (UEMS) — Member · since 2019
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.matthew.winter@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
